Publications by authors named "S Vives"

Claim this Profile
E
Effectiveness of Gilteritinib Beyond Second-Line Therapy in Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia: A Real-World Multicenter Study of 171 Patients.
Matteo Molica, Gema Miralles, Richard Dillon, Mario Annunziata, Faisal Basheer, Susana Vives

Am J Hematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALIDHE phase 3b study design: ivosidenib + azacitidine in adults with newly diagnosed mutant acute myeloid leukemia.
Paresh Vyas, Sam Salek, Susana Vives, Christian Recher, Hartmut Döhner

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient involvement in the design of ALIDHE: a study of ivosidenib + azacitidine in newly diagnosed mutant AML.
Samantha Nier, Jana Pelouchova, Ralph Hills, Sam Salek, Hélène Derrien, Susana Vives

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Quizartinib for Newly Diagnosed -Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.
Pau Montesinos, Rebeca Rodríguez-Veiga, Juan Miguel Bergua, Jesús Lorenzo Algarra Algarra, Carmen Botella, Susana Vives

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A scoring system to predict life-threatening thromboischemic events in patients with acute promyelocytic leukemia: the PETHEMA/PALG study.
Rebeca Rodríguez-Veiga, Cristina Gil, Marta Sobas, Laura Torres-Miñana, Carmen Botella, Susana Vives

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis